CGVHD
Clinical trials for CGVHD explained in plain language.
Never miss a new study
Get alerted when new CGVHD trials appear
Sign up with your email to follow new studies for CGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: drug combo targets stubborn GVHD
Disease control Not yet recruitingThis early-phase trial tests a drug called sarilumab in 10 adults with chronic graft-versus-host disease (cGVHD) that did not improve with the standard treatment belumosudil. The goal is to see if sarilumab is safe and tolerable as a rescue therapy. Participants will receive sari…
Matched conditions: CGVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug gecacitinib offers hope for Hard-to-Treat GVHD
Disease control Not yet recruitingThis study tests a new drug called gecacitinib in 33 adults with chronic graft-versus-host disease (cGVHD) that hasn't improved with steroids. The goal is to find a safe dose and see if it can control the disease. Participants must have had a stem cell transplant and have active …
Matched conditions: CGVHD
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:55 UTC